GlyCosmos Glycolipids
Glycolipid entries from the LIPID MAPS Structure Database (LMSD).
| Database | Last Updated |
|---|---|
| ChEBI | February 3, 2022 |
| KEGG | February 3, 2022 |
| LIPID MAPS Structure Database | February 3, 2022 |
| LipidBank | February 3, 2022 |
| PubChem | February 3, 2022 |
| Main Class | Sub Class | LM ID | Common Name | LipidBank ID | KEGG ID | PubChem CID ▲ | ChEBI ID | Exact Mass | Formula |
|---|---|---|---|---|---|---|---|---|---|
|
Neutral glycosphingolipids
|
GalNAcb1-3Gala1-4Galb1-4Glc- (Globo series)
|
globo-Lex-9(d18:1/22:0)
|
1984.086777
|
C92H165N3O42
|
|||||
|
Neutral glycosphingolipids
|
GalNAcb1-3Gala1-4Galb1-4Glc- (Globo series)
|
globo-Lex-9(d18:1/24:0)
|
2012.118077
|
C94H169N3O42
|
|||||
|
Neutral glycosphingolipids
|
GalNAcb1-3Gala1-4Galb1-4Glc- (Globo series)
|
globo-Lex-9(d18:1/26:0)
|
2040.149377
|
C96H173N3O42
|
|||||
|
Neutral glycosphingolipids
|
GalNAcb1-3Gala1-4Galb1-4Glc- (Globo series)
|
globo-Lex-9(d18:1/24:1(15Z))
|
2010.102427
|
C94H167N3O42
|
|||||
|
Neutral glycosphingolipids
|
GalNAcb1-3Gala1-4Galb1-4Glc- (Globo series)
|
globo-Lex-9(d18:1/26:1(17Z))
|
2038.133727
|
C96H171N3O42
|
|||||
|
Neutral glycosphingolipids
|
GalNAcb1-3Gala1-4Galb1-4Glc- (Globo series)
|
type IV H(d18:1/16:0)
|
1534.860678
|
C72H130N2O32
|
|||||
|
Neutral glycosphingolipids
|
GalNAcb1-3Gala1-4Galb1-4Glc- (Globo series)
|
type IV H(d18:1/18:0)
|
1562.891978
|
C74H134N2O32
|
|||||
|
Neutral glycosphingolipids
|
GalNAcb1-3Gala1-4Galb1-4Glc- (Globo series)
|
type IV H(d18:1/20:0)
|
1590.923278
|
C76H138N2O32
|
|||||
|
Neutral glycosphingolipids
|
GalNAcb1-3Gala1-4Galb1-4Glc- (Globo series)
|
type IV H(d18:1/22:0)
|
1618.954578
|
C78H142N2O32
|
|||||
|
Neutral glycosphingolipids
|
GalNAcb1-3Gala1-4Galb1-4Glc- (Globo series)
|
type IV H(d18:1/24:0)
|
1646.985878
|
C80H146N2O32
|
Displaying entries 191 - 200 of 3908 in total
International Collaboration
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Acknowledgements
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
